Insufficient scRNA-seq data for expression of APOBEC3F at single-cell level.
Insufficient scRNA-seq data for expression of APOBEC3F at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 626.86 | 180 / 180 | 99% | 9.24 | 426 / 430 |
thymus | 100% | 227.98 | 652 / 653 | 99% | 8.72 | 596 / 605 |
uterus | 100% | 362.83 | 170 / 170 | 95% | 8.12 | 436 / 459 |
lung | 100% | 228.89 | 577 / 578 | 93% | 7.77 | 1077 / 1155 |
kidney | 100% | 183.63 | 89 / 89 | 93% | 6.83 | 838 / 901 |
pancreas | 93% | 97.23 | 306 / 328 | 99% | 6.18 | 176 / 178 |
breast | 99% | 202.50 | 454 / 459 | 93% | 6.97 | 1039 / 1118 |
bladder | 100% | 268.33 | 21 / 21 | 91% | 7.99 | 457 / 504 |
esophagus | 99% | 151.44 | 1436 / 1445 | 91% | 7.38 | 167 / 183 |
prostate | 100% | 359.67 | 245 / 245 | 86% | 5.71 | 430 / 502 |
skin | 94% | 149.71 | 1700 / 1809 | 88% | 8.04 | 413 / 472 |
adrenal gland | 100% | 387.76 | 258 / 258 | 79% | 3.70 | 182 / 230 |
stomach | 99% | 140.75 | 354 / 359 | 77% | 4.33 | 219 / 286 |
intestine | 100% | 234.09 | 965 / 966 | 73% | 3.63 | 383 / 527 |
liver | 100% | 127.61 | 225 / 226 | 70% | 4.13 | 284 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 18.03 | 29 / 29 |
spleen | 100% | 660.19 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.75 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 6.80 | 79 / 80 |
peripheral blood | 98% | 506.80 | 915 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 12.42 | 44 / 45 |
adipose | 98% | 163.48 | 1175 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 122.80 | 1289 / 1335 | 0% | 0 | 0 / 0 |
heart | 94% | 107.12 | 806 / 861 | 0% | 0 | 0 / 0 |
brain | 39% | 25.63 | 1032 / 2642 | 35% | 1.62 | 246 / 705 |
muscle | 10% | 5.83 | 84 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045869 | Biological process | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
GO_0045071 | Biological process | negative regulation of viral genome replication |
GO_0016553 | Biological process | base conversion or substitution editing |
GO_0045087 | Biological process | innate immune response |
GO_0051607 | Biological process | defense response to virus |
GO_0070383 | Biological process | DNA cytosine deamination |
GO_0009972 | Biological process | cytidine deamination |
GO_0010526 | Biological process | retrotransposon silencing |
GO_0016554 | Biological process | cytidine to uridine editing |
GO_0044355 | Biological process | clearance of foreign intracellular DNA |
GO_0048525 | Biological process | negative regulation of viral process |
GO_0002230 | Biological process | positive regulation of defense response to virus by host |
GO_0044029 | Biological process | positive regulation of gene expression via chromosomal CpG island demethylation |
GO_0030895 | Cellular component | apolipoprotein B mRNA editing enzyme complex |
GO_0000932 | Cellular component | P-body |
GO_0005737 | Cellular component | cytoplasm |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0005634 | Cellular component | nucleus |
GO_0042802 | Molecular function | identical protein binding |
GO_0004126 | Molecular function | cytidine deaminase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | APOBEC3F |
Protein name | Apolipoprotein B mRNA editing enzyme cytidine deaminase DNA dC->dU-editing enzyme APOBEC-3F (EC 3.5.4.38) (Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3F) (A3F) Apolipoprotein B editing enzyme catalytic polypeptide-like 3F |
Synonyms | |
Description | FUNCTION: DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms. Exhibits antiviral activity against viruse such as HIV-1 or HIV-2 . After the penetration of retroviral nucleocapsids into target cells of infection and the initiation of reverse transcription, it can induce the conversion of cytosine to uracil in the minus-sense single-strand viral DNA, leading to G-to-A hypermutations in the subsequent plus-strand viral DNA . The resultant detrimental levels of mutations in the proviral genome, along with a deamination-independent mechanism that works prior to the proviral integration, together exert efficient antiretroviral effects in infected target cells. Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single- or double-stranded RNA. Exhibits antiviral activity also against hepatitis B virus (HBV), equine infectious anemia virus (EIAV), xenotropic MuLV-related virus (XMRV) and simian foamy virus (SFV) and may inhibit the mobility of LTR and non-LTR retrotransposons. May also play a role in the epigenetic regulation of gene expression through the process of active DNA demethylation. . |
Accessions | ENST00000308521.10 [Q8IUX4-1] M4VR43 Q8IUX4 ENST00000381565.2 [Q8IUX4-3] F2YHL7 |